Catheter Precision, Inc., a U.S.-based innovator in cardiac electrophysiology technologies, has announced its first VIVO™ system purchase order from Sweden, placed by Sahlgrenska University Hospital—one of the country’s most prominent teaching and clinical institutions. The VIVO™ (View Into Ventricular Onset) system is a cutting-edge, non-invasive 3D imaging solution that enables physicians to identify the origin of ventricular arrhythmias before performing procedures. By providing accurate pre-procedural mapping, VIVO streamlines workflow, improves clinical efficiency, and reduces the overall time and complexity of ventricular ablation procedures.
Sahlgrenska University Hospital, serving more than 350,000 patients annually and hosting the region’s largest ventricular ablation program, is a significant early adopter for the VIVO technology. As a teaching hospital, its adoption of VIVO offers dual benefits: enhancing current patient care while training future electrophysiologists on state-of-the-art technology. This strategic placement creates a long-term opportunity for Catheter Precision, as new clinicians gain experience with VIVO and carry that preference into future clinical settings.
This milestone not only marks VIVO’s entry into the Swedish market but also strengthens Catheter Precision’s presence in Europe. With FDA clearance and CE Mark approval, VIVO is gaining international traction as a safer, more efficient alternative for ventricular arrhythmia mapping. Its adoption by a high-volume, academically driven institution underscores its clinical value and long-term potential. As hospitals increasingly seek to balance innovation with efficiency, VIVO offers a compelling solution at the intersection of precision, training, and improved patient outcomes.
MedTech Spectrum's Summary
Strategic European Expansion: Catheter Precision received its first VIVO™ system order from Sahlgrenska University Hospital, Sweden’s largest hospital and a leader in ventricular ablation—marking a key entry into the Scandinavian market.
Innovation in Cardiac Care: The VIVO™ system offers non-invasive, 3D pre-procedural mapping of ventricular arrhythmias, improving procedural planning, reducing operating time, and enhancing treatment precision.
Long-Term Growth Opportunity: Adoption by a major teaching hospital not only boosts clinical credibility but also helps train the next generation of electrophysiologists on VIVO, fostering future demand and broader market penetration.
